TCL Archive “Roller-Coaster Budget” For NIH Criticized On Capitol Hill; $1 Billion Cut By FY 2000? March 17, 1995
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s. February 25, 2000
TCL Archive HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report July 10, 1998
TCL Archive NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000 June 26, 1998
